AGL — Agilon Health Cashflow Statement
0.000.00%
Last trade - 00:00- $270.39m
- -$21.67m
- $6.06bn
Annual cashflow statement for Agilon Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -60.1 | -407 | -107 | -263 | -260 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -10.9 | 302 | 21.2 | 96.5 | 47.3 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 6.47 | -55 | -59.4 | -10.1 | 131 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -53.2 | -148 | -131 | -156 | -57.8 |
| Capital Expenditures | -2.35 | -13.4 | -32.7 | -30.8 | -41.3 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 24.4 | -77.1 | -412 | -13.2 | 181 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 22.1 | -90.5 | -444 | -44 | 140 |
| Financing Cash Flow Items | 0 | -14.7 | 0 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 24.6 | 1,154 | 28.1 | -193 | -2.58 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6.52 | 916 | -547 | -393 | 79.5 |